Search | IOVS | ARVO Journals

Showing 1 – 20 of 26

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles June 2019

Age-Related Loss of Human Vitreal Viscoelasticity

PDF

André Schulz; Silke Wahl; Annekatrin Rickmann; Jannine Ludwig; Boris V. Stanzel; Hagen von Briesen; Peter Szurman
TAGS: viscoelasticity, vitreous body
Trans. Vis. Sci. Tech.. 2019; 8(3):56. doi: 10.1167/tvst.8.3.56

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Improved cryopreservation of cultured RPE with addition of a silver iodide/ alginate mixture

Boris V. Stanzel; Andre Schulz; Iris Riemann; Michael M. Gepp; Julia Neubauer; Peter Szurman; Hagen von Briesen; Heiko Zimmermann; Frank Stracke

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4022. doi:

ARVO Annual Meeting Abstract June 2017

OCT Characteristics Among Subjects Implanted with the Argus II Retinal Prosthesis System; the Argus II OCT Study Group

Catherine Hoeppner; Natalia F Callaway; Ninel Gregori; Byron L Lam; Hossein Ameri; Albert J Augustin; Allen Ho; Raymond Iezzi; Thiran Jayasundera; Gregg Kokame; Jennifer I Lim; Peter Szurman; Lejla Vajzovic; Peter MH Wiedemann; Jiong Yan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4267. doi:

ARVO Annual Meeting Abstract September 2016

Suprachoroidal hydrogel buckling as a surgical treatment of retinal detachment - biocompatibility and first experiences

Kai Januschowski; Karl Boden; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1036. doi:

ARVO Annual Meeting Abstract June 2015

A minimal invasive implantable sensor for telemetric intraocular pressure monitoring

Siegfried Mariacher; Martina Ebner; Kai Januschowski; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):109. doi:

ARVO Annual Meeting Abstract June 2015

Customized Iris Prosthesis in eyes with post-traumatic aniridia

Anja Nessmann; Julia Wagner; Efdal Yoeruek; Karl Ulrich Bartz-Schmidt; Peter Szurman; Martin Stephan Spitzer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):6060. doi:

ARVO Annual Meeting Abstract June 2015

UV-Cross-Linked Hyaluronic Acid as Vitreous Substitute - OCT, histological and immunohistochemical results 12 months after implantation

Martin Stephan Spitzer; Charlotte Schramm; Tomek Mlynczak Mlynczak; Peter Szurman; Sven Schnichels; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5108. doi:

ARVO Annual Meeting Abstract June 2015

Investigating Retinal Toxicity of a Lutein-Based Dye in a Model of Isolated and Perfused Bovine Retina

Sebastian Mueller; Carlo Krupp; Sven Schnichels; Johanna Hofmann; Martin Stephan Spitzer; Karl Ulrich Bartz-Schmidt; Peter Szurman; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5737. doi:

ARVO Annual Meeting Abstract June 2015

An ex-vivo model for the short term IOP development for vitreous tamponades

Kai Januschowski; Siegfried Mariacher; Martina Ebner; sven schnichels; jose hurst; Peter Szurman; Karl Ulrich Bartz-Schmidt; Martin Stephan Spitzer; Johanna Hofmann, Lisa Pohl, Nele Schneider,

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):211. doi:

ARVO Annual Meeting Abstract June 2013

Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol

Sebastian Mueller; Rebecca Dollinger; Sebastian Thaler; Johanna Hofmann; Martin Spitzer; Karl Bartz-Schmidt; Peter Szurman; Kai Januschowski

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):413. doi:

ARVO Annual Meeting Abstract March 2012

Long-Term In Vivo Biocompatibility of UV-Cross-Linked Hyaluronic Acid as Vitreous Replacement - 12 Months Results

Martin S. Spitzer; Charlotte Schramm; Tomasz Mlynczak; Maximilian Schultheiss; Sven Schnichels; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3767. doi:

ARVO Annual Meeting Abstract March 2012

Evaluating Retinal Toxicity of a New Heavy Intraocular Dye Using the Model of Perfused and Isolated Retinal Cultures of Human Origin

Sebastian Mueller; Kai Januschowski; Martin Spitzer; Charlotte Schramm; Karl-Ulrich Bartz-Schmidt; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5373. doi:

ARVO Annual Meeting Abstract March 2012

Comparison of Real Ray Tracing and Topography Based to Conventional Formula and Keratometry Based Intraocular Lens Calculation

Thomas Bende; Jens Einighammer; Peter Szurman; Katrin Petermeier

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1371. doi:

ARVO Annual Meeting Abstract March 2012

Effects Of Bevacizumab On Intraocular Pressure Influenced By The Trabecular Meshwork

Kai Januschowski; Charlotte Schramm; Oliver Ottmann; Karl Bartz-Schmidt; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1991. doi:

Retina February 2012

The Cross-linked Biopolymer Hyaluronic Acid as an Artificial Vitreous Substitute

PDF

Charlotte Schramm; Martin S. Spitzer; Sigrid Henke-Fahle; Gabriele Steinmetz; Kai Januschowski; Peter Heiduschka; Jürgen Geis-Gerstorfer; Tilo Biedermann; Karl U. Bartz-Schmidt; Peter Szurman
TAGS: biopolymers, burkina faso, hyaluronic acid, hydrogel, hydrogels, ultraviolet rays, vitreous substitute, biocompatibility
Invest. Ophthalmol. Vis. Sci.. 2012; 53(2):613-621. doi: 10.1167/iovs.11-7322

Clinical Trials July 2011

Spatial Resolution and Perception of Patterns Mediated by a Subretinal 16-Electrode Array in Patients Blinded by Hereditary Retinal Dystrophies

PDF

Robert Wilke; Veit-Peter Gabel; Helmut Sachs; Karl-Ulrich Bartz Schmidt; Florian Gekeler; Dorothea Besch; Peter Szurman; Alfred Stett; Barbara Wilhelm; Tobias Peters; Alex Harscher; Udo Greppmaier; Steffen Kibbel; Heval Benav; Anna Bruckmann; Katarina Stingl; Akos Kusnyerik; Eberhart Zrenner
TAGS: perception, accommodation phosphene, implantation procedure, implants, hereditary retinal dystrophy
Invest. Ophthalmol. Vis. Sci.. 2011; 52(8):5995-6003. doi: 10.1167/iovs.10-6946

ARVO Annual Meeting Abstract April 2011

Uv-crosslinked Hyaluronic Acid As An Intraocular Slow Release System For Dexamethasone

Charlotte Schramm; Karolin Adler; Martin S. Spitzer; Kai Januschowski; Karl-Ullrich Bartz-Schmidt; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):452. doi:

ARVO Annual Meeting Abstract April 2011

Trichostatin A Induces Cell Death At The Concentration Recommended To Differentiate The RGC-5 Cell Line

Sven Schnichels; Maximilian Schultheiss; Johanna Hofmann; Peter Szurman; Karl U. Bartz-Schmidt; Martin S. Spitzer

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4595. doi:

ARVO Annual Meeting Abstract April 2011

Staurosporine Induced "Differentiation" of the RGC-5 Cell Line Leads to Apoptosis and Cell Death at the Lowest Cell-Morphology-Changing Concentration

Maximilian Schultheiss; Sven Schnichels; Kapka Miteva; Katrin Warstat; Peter Szurman; Martin S. Spitzer; Sophie van Linthout

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4608. doi:

ARVO Annual Meeting Abstract April 2011

Testing The Biocompatibility Of Two New Heavy Intraocular Dyes For Vitreoretinal Surgery Using An Isolated Perfused Vertebrate Retina Organ Culture Model And Retinal Ganglion Cells

Kai Januschowski; Sebastian Mueller; Martin Spitzer; Johanna Hofmann; Charlotte Schramm; Maximilian Schultheiß; Karl-Ulrich Barth-Schmidt; Peter Szurman

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5670. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Age-Related Loss of Human Vitreal Viscoelasticity

Improved cryopreservation of cultured RPE with addition of a silver iodide/ alginate mixture

OCT Characteristics Among Subjects Implanted with the Argus II Retinal Prosthesis System; the Argus II OCT Study Group

Suprachoroidal hydrogel buckling as a surgical treatment of retinal detachment - biocompatibility and first experiences

A minimal invasive implantable sensor for telemetric intraocular pressure monitoring

Customized Iris Prosthesis in eyes with post-traumatic aniridia

UV-Cross-Linked Hyaluronic Acid as Vitreous Substitute - OCT, histological and immunohistochemical results 12 months after implantation

Investigating Retinal Toxicity of a Lutein-Based Dye in a Model of Isolated and Perfused Bovine Retina

An ex-vivo model for the short term IOP development for vitreous tamponades

Investigating Retinal Toxicity of the Potentially Neuroprotective Substance Tempol

Long-Term In Vivo Biocompatibility of UV-Cross-Linked Hyaluronic Acid as Vitreous Replacement - 12 Months Results

Evaluating Retinal Toxicity of a New Heavy Intraocular Dye Using the Model of Perfused and Isolated Retinal Cultures of Human Origin

Comparison of Real Ray Tracing and Topography Based to Conventional Formula and Keratometry Based Intraocular Lens Calculation

Effects Of Bevacizumab On Intraocular Pressure Influenced By The Trabecular Meshwork

The Cross-linked Biopolymer Hyaluronic Acid as an Artificial Vitreous Substitute

Spatial Resolution and Perception of Patterns Mediated by a Subretinal 16-Electrode Array in Patients Blinded by Hereditary Retinal Dystrophies

Uv-crosslinked Hyaluronic Acid As An Intraocular Slow Release System For Dexamethasone

Trichostatin A Induces Cell Death At The Concentration Recommended To Differentiate The RGC-5 Cell Line

Staurosporine Induced "Differentiation" of the RGC-5 Cell Line Leads to Apoptosis and Cell Death at the Lowest Cell-Morphology-Changing Concentration

Testing The Biocompatibility Of Two New Heavy Intraocular Dyes For Vitreoretinal Surgery Using An Isolated Perfused Vertebrate Retina Organ Culture Model And Retinal Ganglion Cells

To View More...

You must be signed into an individual account to use this feature.